TELA Bio (TELA) Income from Continuing Operations (2018 - 2026)
TELA Bio's quarterly Income from Continuing Operations came in at 12273000.0 in Q1 2026, down 8.96% year-on-year from 13480553.1 in Q1 2025, and down 29.83% quarter-over-quarter from 9453000.0 in Q4 2025.
TELA Bio has reported Income from Continuing Operations for 9 years, with the latest figure at 12273000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 8.96% year-over-year to 12273000.0; the trailing twelve-month figure through Mar 2026 stood at 40252000.0 (down 706.98% YoY), and the FY2025 full-year result was 39243000.0, down 5270.36% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 12273000.0, down from 9453000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 29248000.0 in Q4 2024, with the low at 13623000.0 in Q4 2023.
- Average Income from Continuing Operations over 5 years is 8426882.35, with a median of 10755000.0 recorded in 2022.
- Year-over-year, Income from Continuing Operations soared 314.7% in 2024 and tumbled 132.32% in 2025.
- Tracing TELA's Income from Continuing Operations over 5 years: stood at 10613000.0 in 2022, then retreated by 28.36% to 13623000.0 in 2023, then surged by 314.7% to 29248000.0 in 2024, then plunged by 132.32% to 9453000.0 in 2025, then decreased by 29.83% to 12273000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 12273000.0 (Q1 2026), 9453000.0 (Q4 2025), and 8603000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -12.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.27 Mn |
| Dec 31, 2025 | -9.45 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -13.62 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -11.66 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -10.61 Mn |
| Sep 30, 2022 | -10.52 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -10.76 Mn |
| Dec 31, 2021 | -8.58 Mn |
| Sep 30, 2021 | -8.14 Mn |
| Jun 30, 2021 | -8.18 Mn |
| Mar 31, 2021 | -8.16 Mn |
| Dec 31, 2020 | -7.65 Mn |
| Sep 30, 2020 | -7.76 Mn |
| Jun 30, 2020 | -6.05 Mn |
| Mar 31, 2020 | -7.38 Mn |
| Dec 31, 2019 | -6.71 Mn |
| Sep 30, 2019 | -4.76 Mn |
| Jun 30, 2019 | -5.21 Mn |
| Mar 31, 2019 | -6.09 Mn |
| Dec 31, 2018 | -6.26 Mn |
| Sep 30, 2018 | -2.83 Mn |